Kaléo unveils 58 layoffs days after pledging to double in-office commercial team for EpiPen rival Auvi-Q
After Kaléo unveiled a “redesign” of the in-office commercial team for its EpiPen rival Auvi-Q at the start of the month, the privately held company has announced a fresh round of job cuts in the U.S. As part of a “mass layoff” of sales representatives, …